What Does MACD Oscillator Analysis predict about HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)?

70

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) for the period of 9-Day stands at 79.51% while the stochastic %D for the same period stands at 76.59%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)’s 20-Day Bollinger Band indicates “Buy”.

About Company

HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona.

Previous Day Activity Analysis

On the last trading day, HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) opened the session at $2.5 and after going down -5.2% closed at $2.37. The stock lost -0.13 points in the last trade.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)’s stock fluctuated in the range of $2.30 and $2.52 during the previous active session. HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) traded with the volume of 1.14 Million with average volume of 613.24 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.21 and 63.97 respectively.

Currently the Insider Ownership of the shares of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is at 2.5% and the shares outstanding are 11.77 Million.

Important Ratio Analysis

Some important ratios to consider here for HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) are discussed below:

Dividend yield of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 5.07 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.17 and 0 correspondingly.

The Quick Ratio of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) stands at 0.7 while the Current Ratio depicts the value of 0.8.

Return on Assets ROA of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is at -123% whereas, Return on Equity ROE and Return of Investment ROI of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) stand at 706.1% and -164.5% respectively.

Stock Performance Analysis

The stock performance of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) on the basis of 5 day trade show the jump of 24.74% whereas, the monthly performance of the stock shows increase of 28.8%.

The quarterly performance of the stock remained in green zone with the value of 2.16% while six month performance of the shares of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) remained bearish with the count of -56.59%.

The yearly and YTD performance of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) remained mix at -9.89% and 5.8% respectively.

LEAVE A REPLY